USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
The Russian Biopharmaceuticals and Biomedicine Market
The Russian Biopharmaceuticals and Biomedicine Market
From Import Substitution to Innovation
RELEASE DATE
16-Dec-2014
16-Dec-2014
REGION
Europe
Europe
Research Code: 9AB9-00-15-00-00
SKU: LS00069-EU-MR_16910
$1,500.00
In stock
SKU
LS00069-EU-MR_16910
Description
This study covers the Russian biopharmaceutical and biomedicine markets. Key segments for the biopharmaceutical market include cytokines, monoclonal antibodies, vaccines, and antibiotics. The biomedicine market includes regenerative medicine, nanomedicine, biocompatible medical materials, diagnostics, post-genomic technologies, and bioinformatics. This research shows the latest developments in Russian biotechnology, defines key segments and emerging leaders, and outlines government policies and support mechanisms. The base year for the study is 2013 with a forecast period of 2014 to 2018.
Table of Contents
Executive Summary (continued)
Executive Summary
Key Companies to Watch in 2015
Research Scope and Objective
Russian Economy Overview
Healthcare Market Overview
Biopharmaceuticals Market Overview
Biopharmaceuticals Market Overview (continued)
Market Drivers
Drivers—Explained
Market Restraints
Restraints—Explained
Russian Biopharmaceuticals Market—Revenue Forecast
Regulatory Environment
Complex Program for Development of Biotechnology in the Russian Federation Until 2020
Complex Program for Development of Biotechnology in the Russian Federation Until 2020 (continued)
Key Government Support Mechanisms—Overview
Key Government Support Mechanisms—Biotech Clusters
Key Government Support Mechanisms—Biotech Clusters (continued)
Key Government Support Mechanisms—Technology Platforms
Key Government Support Mechanisms—ZHNVLP List and Import Substitution
Biotechnology Investment—State Development Institutions
Biotechnology Investment—Venture Capital
Biopharmaceuticals Market—Percent Revenue Breakdown by Segment
Biopharmaceuticals Segment Overview—Cytokines
Biopharmaceuticals Segment Overview—PKI and Coagulants
Biopharmaceuticals Segment Overview—Hormones
Biopharmaceuticals Segment Overview—Monoclonal Antibodies
Vaccines Segment
Vaccines Segment (continued)
Vaccines Segment (continued)
Vaccines Segment (continued)
Vaccines Segment (continued)
Antibiotics and Bacteriophages
Antibiotics and Bacteriophages (continued)
Antibiotics and Bacteriophages (continued)
Biomedicine Market Overview
Biomedicine Market Overview (continued)
Market Drivers
Drivers—Explained
Market Restraints
Restraints—Explained
Cell Technologies, Gene Therapy, and Regenerative Medicine
Cell Technologies, Gene Therapy, and Regenerative Medicine (continued)
Cell Technologies, Gene Therapy, and Regenerative Medicine (continued)
Nanomedicine and Targeted Drug Delivery
Nanomedicine and Targeted Drug Delivery (continued)
Biocompatible and Biodegradable Medical Materials
Biocompatible and Biodegradable Medical Materials (continued)
Biocompatible and Biodegradable Medical Materials—Projects of TP “Medicine of the Future”
Biocompatible and Biodegradable Medical Materials—Projects of TP “Medicine of the Future” (continued)
Biocompatible and Biodegradable Medical Materials—Projects of TP “Medicine of the Future” (continued)
Diagnostics Systems, Biochips, and Biosensors
Diagnostics Systems, Biochips, and Biosensors (continued)
Diagnostics Systems, Biochips, and Biosensors (continued)
Systems Biology, Post-genomics Technologies, Bioinformatics
Systems Biology, Post-genomics Technologies, Bioinformatics (continued)
Systems Biology, Post-genomics Technologies, Bioinformatics (continued)
Systems Biology, Post-genomics Technologies, Bioinformatics (continued)
Three Big Predictions
Legal Disclaimer
Import Substitution of Biopharmaceuticals From the ZHNVLP List
Import Substitution of Biopharmaceuticals From the ZHNVLP List (continued)
Import Substitution of Biopharmaceuticals From the ZHNVLP List (continued)
List of Acronyms
The Frost & Sullivan Story
Value Proposition
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
This study explores Western Europes dynamic next generation sequencing (NGS) market. The majority of the quantitative and qualitative information was acquired through primary research conducted with NGS providers. The market is broadly classified into 2 major segments: instruments and reagents, and 2 subsegments: research use only and clinical diagnostic use. Geographic segmentation covers the United Kingdom, Germany, France, Spain, Italy, Benelux, and Scandinavia. Also, the study includes a competitive analysis (SWOT), product analysis, revenue forecasts, and market share using a base year of 2013 and a 20142018 forecast period. A list of key sequencing service providers for each country or region is included.
| No Index | No |
|---|---|
| Podcast | No |
| Author | Dmitry Raspopov |
| WIP Number | 9AB9-00-15-00-00 |
| Is Prebook | No |